HMN-214 is primarily investigated for its potential applications in cancer therapy. It functions as a potent inhibitor of certain kinases, which are enzymes that play a critical role in cell signaling and cancer progression. By targeting these kinases, HMN-214 can disrupt the signaling pathways that promote tumor growth and survival. This makes it a promising candidate for the development of targeted cancer treatments, particularly for cancers that are driven by the overactivity of these specific kinases. Research is ongoing to explore its efficacy, safety, and potential use in combination with other therapeutic agents to enhance its anticancer effects.